Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

68Ga-FAPI Avidity in Fat Necrosis and Adrenal Adenoma: Expanding the Spectrum of Benign Pitfalls in Oncologic Imaging.

Created on 23 Jun 2026

Authors

Serin Moghrabi, Raghad Mohammad Al-Houwari, Baraa Alsyouf, Akram Al-Ibraheem

Published in

Molecular imaging and radionuclide therapy. Jun 23, 2026. Epub Jun 23, 2026.

Abstract

Fat necrosis, a benign postoperative process related to tissue injury and repair, may demonstrate variable findings on functional imaging. We report a case of postoperative fat necrosis following pancreaticoduodenectomy showing intense 68Ga-FAPI uptake in the absence of significant 18F-fluorodeoxyglucose (18F-FDG) avidity. Surveillance 18F-FDG positron emission tomography/computed tomography (18F-FDG PET/CT) demonstrated only mild activity within the surgical bed maximum standard uptake value (SUVmax 2.4), while subsequent 68Ga-FAPI PET/CT revealed marked uptake corresponding to fat necrosis SUVmax 9.9, consistent with pronounced fibroblast activation during postoperative healing. Additionally, a benign left adrenal adenoma showed low 18F-FDG uptake and only minimal 68Ga-FAPI avidity (SUVmax 2.3), reflecting minimal stromal activation. This case highlights the tracer discordance between 18F-FDG and 68Ga-FAPI in fat necrosis and underscores the importance of correlating 68Ga-FAPI findings with surgical history and anatomic imaging to ensure accurate interpretation.

PMID:
42334269
Bibliographic data and abstract were imported from PubMed on 23 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement